Maturitas · 2026
Serum 25-hydroxyvitamin D concentrations, sleep characteristics and the risk of incident dementia.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ren Jiao-Jiao, Li Zhi-Hao, Zhong Wen-Fang, Gao Jian, Chen Pei-Liang, Wang Xiao-Meng, You Fang-Fei, Mao Chen
Аннотация
OBJECTIVES: Serum 25-hydroxyvitamin D concentrations have been associated with the risk of dementia, but the results are inconsistent. Previous studies have reported that vitamin D metabolism is related to sleep characteristics. We investigated the association between serum 25-hydroxyvitamin D concentrations and the risk of dementia, as well as whether sleep characteristics and sleep patterns modified this association.
STUDY DESIGN: In this prospective population-based cohort study, serum 25-hydroxyvitamin D concentrations were measured. Sleep characteristics, including sleep duration, chronotype, sleeplessness, snoring, and daytime sleepiness, were integrated to generate an overall sleep pattern. We used a multivariable adjusted Cox proportional hazards regression model to evaluate the association of serum 25-hydroxyvitamin D concentrations with the risk of incident dementia.
RESULTS: Over a median follow-up of 13.7 years, there were 7030 cases of all-cause dementia, including 3089 of Alzheimer's disease and 1539 of vascular dementia in the cohort of 366,160 participants. Higher concentrations of serum 25-hydroxyvitamin D were associated with a lower risk of all-cause dementia, Alzheimer's disease and vascular dementia. We found a statistically significant interaction of modest magnitude between serum 25-hydroxyvitamin D concentrations and sleep patterns with the risk of vascular dementia (P interaction = 0.04). Among the sleep characteristics, an interaction was found between serum 25-hydroxyvitamin D concentrations and daytime sleepiness in their effect on the risk of vascular dementia (P interaction = 0.03). The protective hazard ratios for vascular dementia were more pronounced in individuals with low daytime sleepiness than in those with high daytime sleepiness.
CONCLUSIONS: Serum 25-hydroxyvitamin D concentrations were inversely associated with the risks of all-cause dementia, Alzheimer's disease and vascular dementia. Sleep characteristics, particularly daytime sleepiness, may modify the association between serum 25-hydroxyvitamin D concentrations and the risk of vascular dementia.
STUDY DESIGN: In this prospective population-based cohort study, serum 25-hydroxyvitamin D concentrations were measured. Sleep characteristics, including sleep duration, chronotype, sleeplessness, snoring, and daytime sleepiness, were integrated to generate an overall sleep pattern. We used a multivariable adjusted Cox proportional hazards regression model to evaluate the association of serum 25-hydroxyvitamin D concentrations with the risk of incident dementia.
RESULTS: Over a median follow-up of 13.7 years, there were 7030 cases of all-cause dementia, including 3089 of Alzheimer's disease and 1539 of vascular dementia in the cohort of 366,160 participants. Higher concentrations of serum 25-hydroxyvitamin D were associated with a lower risk of all-cause dementia, Alzheimer's disease and vascular dementia. We found a statistically significant interaction of modest magnitude between serum 25-hydroxyvitamin D concentrations and sleep patterns with the risk of vascular dementia (P interaction = 0.04). Among the sleep characteristics, an interaction was found between serum 25-hydroxyvitamin D concentrations and daytime sleepiness in their effect on the risk of vascular dementia (P interaction = 0.03). The protective hazard ratios for vascular dementia were more pronounced in individuals with low daytime sleepiness than in those with high daytime sleepiness.
CONCLUSIONS: Serum 25-hydroxyvitamin D concentrations were inversely associated with the risks of all-cause dementia, Alzheimer's disease and vascular dementia. Sleep characteristics, particularly daytime sleepiness, may modify the association between serum 25-hydroxyvitamin D concentrations and the risk of vascular dementia.